Sustainable prescribing of GLP-1s coming to Employer Health Plans
As the demand for GLP-1 medications like Mounjaro and Ozempic continues to grow, employers are facing rising healthcare costs tied to diabetes and weight management. In response, Barakat’s expanded GLP-1 program is offering large employers a cost-effective solution—without compromising on quality or clinical support.
Cutting Costs While Improving Outcomes
Employers providing GLP-1 medications for diabetes and weight loss often struggle with two challenges: high drug costs and long-term sustainability. Barakat’s program is designed to address both, helping companies save between 15-25% per diabetes member and 35-50% per weight loss member after one year.
The program leverages Tier 1 international sourcing (USA, Canada and UK) of branded Mounjaro and Ozempic—a strategy that keeps costs lower while ensuring members receive the highest-quality medications. Estimated costs for employers include:
- $7,000 – $8,500 per year for diabetes members using Mounjaro
- $5,000 – $6,000 per year for weight loss members using Mounjaro
Unlike traditional approaches that rely solely on medication, this initiative ensures that participants receive comprehensive clinical support and a structured pathway to maintain results even after stopping GLP-1s.
Beyond the Medication: A Sustainable Approach
Barakat’s program goes beyond prescription access by offering 24/7 clinician support, lab testing, and real-time health monitoring. Clinicians specializing in diabetes and weight management oversee members, helping them:
✔ Understand how food affects their metabolism
✔ Improve blood glucose control through lifestyle changes
✔ Follow a clear transition plan off GLP-1s when appropriate
This approach ensures that employees see long-term health benefits, reducing the risk of weight regain or worsening metabolic conditions after discontinuing medication.
Flexible Funding for Employers
For employers concerned about budget impact, Barakat has structured a separate funding arrangement outside of traditional health plans, allowing companies to carve out GLP-1s if needed.
With a growing number of organizations seeking cost-effective, clinically responsible solutions, Barakat’s expansion offers a financially sustainable way to support employees’ health without breaking the benefits budget.
For more details, contact cbarakat@woopcare.com.
This article originated: http://blog.riskmanagers.us/barakats-glp-1-weight-management-program/
